These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 34216835)

  • 1. AI-based language models powering drug discovery and development.
    Liu Z; Roberts RA; Lal-Nag M; Chen X; Huang R; Tong W
    Drug Discov Today; 2021 Nov; 26(11):2593-2607. PubMed ID: 34216835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of artificial intelligence and machine learning for COVID-19 drug discovery and vaccine design.
    Lv H; Shi L; Berkenpas JW; Dao FY; Zulfiqar H; Ding H; Zhang Y; Yang L; Cao R
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34410360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging role of artificial intelligence in therapeutics for COVID-19: a systematic review.
    Kaushal K; Sarma P; Rana SV; Medhi B; Naithani M
    J Biomol Struct Dyn; 2022 Jul; 40(10):4750-4765. PubMed ID: 33300456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of artificial intelligence and machine learning in drug repurposing.
    Ghandikota SK; Jegga AG
    Prog Mol Biol Transl Sci; 2024; 205():171-211. PubMed ID: 38789178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial intelligence for the discovery of novel antimicrobial agents for emerging infectious diseases.
    Bess A; Berglind F; Mukhopadhyay S; Brylinski M; Griggs N; Cho T; Galliano C; Wasan KM
    Drug Discov Today; 2022 Apr; 27(4):1099-1107. PubMed ID: 34748992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Language Processing for Smart Healthcare.
    Zhou B; Yang G; Shi Z; Ma S
    IEEE Rev Biomed Eng; 2024; 17():4-18. PubMed ID: 36170385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions.
    Vatansever S; Schlessinger A; Wacker D; Kaniskan HÜ; Jin J; Zhou MM; Zhang B
    Med Res Rev; 2021 May; 41(3):1427-1473. PubMed ID: 33295676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial Intelligence for Quantitative Modeling in Drug Discovery and Development: An Innovation and Quality Consortium Perspective on Use Cases and Best Practices.
    Terranova N; Renard D; Shahin MH; Menon S; Cao Y; Hop CECA; Hayes S; Madrasi K; Stodtmann S; Tensfeldt T; Vaddady P; Ellinwood N; Lu J
    Clin Pharmacol Ther; 2024 Apr; 115(4):658-672. PubMed ID: 37716910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piquing artificial intelligence towards drug discovery: Tools, techniques, and applications.
    Agu PC; Obulose CN
    Drug Dev Res; 2024 Apr; 85(2):e22159. PubMed ID: 38375772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-Omics and Artificial Intelligence-Guided Drug Repositioning: Prospects, Challenges, and Lessons Learned from COVID-19.
    Cong Y; Endo T
    OMICS; 2022 Jul; 26(7):361-371. PubMed ID: 35759424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial intelligence revolutionizing drug development: Exploring opportunities and challenges.
    Tiwari PC; Pal R; Chaudhary MJ; Nath R
    Drug Dev Res; 2023 Dec; 84(8):1652-1663. PubMed ID: 37712494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial Intelligence in Accelerating Drug Discovery and Development.
    Tripathi A; Misra K; Dhanuka R; Singh JP
    Recent Pat Biotechnol; 2023; 17(1):9-23. PubMed ID: 35927896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of an Artificial Intelligence Trilogy to Accelerate Processing of Suspected Patients With SARS-CoV-2 at a Smart Quarantine Station: Observational Study.
    Liu PY; Tsai YS; Chen PL; Tsai HP; Hsu LW; Wang CS; Lee NY; Huang MS; Wu YC; Ko WC; Yang YC; Chiang JH; Shen MR
    J Med Internet Res; 2020 Oct; 22(10):e19878. PubMed ID: 33001832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial Intelligence in Pharmacovigilance: An Introduction to Terms, Concepts, Applications, and Limitations.
    Aronson JK
    Drug Saf; 2022 May; 45(5):407-418. PubMed ID: 35579806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based drug repurposing: Traditional and advanced AI/ML-aided methods.
    Choudhury C; Arul Murugan N; Priyakumar UD
    Drug Discov Today; 2022 Jul; 27(7):1847-1861. PubMed ID: 35301148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent omics-based computational methods for COVID-19 drug discovery and repurposing.
    Tayara H; Abdelbaky I; To Chong K
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34423353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating clinical pharmacology and artificial intelligence: potential benefits, challenges, and role of clinical pharmacologists.
    Singh H; Nim DK; Randhawa AS; Ahluwalia S
    Expert Rev Clin Pharmacol; 2024 Apr; 17(4):381-391. PubMed ID: 38340012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial intelligence approach fighting COVID-19 with repurposing drugs.
    Ke YY; Peng TT; Yeh TK; Huang WZ; Chang SE; Wu SH; Hung HC; Hsu TA; Lee SJ; Song JS; Lin WH; Chiang TJ; Lin JH; Sytwu HK; Chen CT
    Biomed J; 2020 Aug; 43(4):355-362. PubMed ID: 32426387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial intelligence in small molecule drug discovery from 2018 to 2023: Does it really work?
    Lv Q; Zhou F; Liu X; Zhi L
    Bioorg Chem; 2023 Dec; 141():106894. PubMed ID: 37776682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behind the scenes: A medical natural language processing project.
    Wu JT; Dernoncourt F; Gehrmann S; Tyler PD; Moseley ET; Carlson ET; Grant DW; Li Y; Welt J; Celi LA
    Int J Med Inform; 2018 Apr; 112():68-73. PubMed ID: 29500024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.